An interactive data dashboard monitoring how states across the United States are responding to growing policy and public health concerns surrounding kratom and its active alkaloid 7-hydroxymitragynine (7-OH).
On October 14, 2026, the Drug Enforcement Administration issued a notice of intent to publish a temporary order to schedule 7-OH and mitragynine pseudoindoxyl—two of the compounds found in kratom—above a specified threshold as Schedule I drugs. This replaces a previous notice of intent that was released in July 2026 to schedule 7-OH and mitragynine pseudoindoxyl at lower thresholds. A scheduling order will need to be posted to make this scheduling effective. An August 25, 2026 temporary scheduling order classifying three semisynthetic kratom compounds—mitragynine pseudoindoxyl (MGPI), MGM-15, and MGM-16—as Schedule I substances remains in place until August 26, 2028, when it can be extended or made permanent.
| State | Bans/Schedules | Potency Caps | Sales Restrictions | Introduced Legislation | Notes |
|---|
| Locality | Government Type | Ban Type | Other Regulation | Method | Status | Effective Date |
|---|
